AI
AI

Tag: AbbVie

AbbVie Stock Rises Following Strong Earnings Report and Upward Guidance

Photo credit: www.investopedia.com Market Update: S&P 500 Continues Winning Streak Amid Mixed Performance Key Takeaways The S&P 500 increased by 0.1% on...

AbbVie Raises Profit Outlook Amid Robust Sales of New Immunology Treatments

Photo credit: finance.yahoo.com (Reuters) - AbbVie has increased its profit forecast for 2025 following impressive sales performance from its newer...

Here’s the Number of AbbVie Shares Required for $1,000 in Annual Dividends

Photo credit: www.fool.com Considering an investment in AbbVie (ABBV -0.34%) for its appealing dividend potential? If your goal is to...

AbbVie Emerges as a New Contender in the Weight Loss Drug Market

Photo credit: www.cnbc.com A sign stands outside an Abbvie facility in Cambridge, Massachusetts.The competitive landscape of weight loss medications is...

Apple, AbbVie, Deckers Outdoor, and Other Notable Companies

Photo credit: www.investopedia.com Midday Market Update: U.S. Equities Mostly Higher on Strong Earnings and Inflation Data Key Takeaways The U.S. stock market...

AbbVie and Neomorph Collaborate on Protein Degrader Medications – Investing.com

Photo credit: www.investing.com AbbVie and Neomorph Collaborate to Develop Innovative Cancer Therapies NORTH CHICAGO, Ill. - AbbVie (NYSE: NYSE:), a major...

AbbVie Posts $3.5B Impairment Charge Due to Schizophrenia Drug Setback

Photo credit: www.investopedia.com AbbVie Faces Setback with $3.5 Billion Impairment Charge Key Takeaways Biopharmaceutical company AbbVie has announced plans to take a...

AbbVie Acquires Aliada to Strengthen Alzheimer’s Treatment Options – Investing.com

Photo credit: www.investing.com AbbVie Expands Neuroscience Portfolio with Acquisition of Aliada Therapeutics NORTH CHICAGO, Ill. - AbbVie, a leading pharmaceutical firm...

Looking to Invest $1,500? AbbVie Just Confirmed the Case for Bullish Sentiment on Its Stock

Photo credit: www.fool.com AbbVie has successfully addressed one of the most significant challenges to its financial health, marking a pivotal...

Why AbbVie Stock Took a Hit on Monday

Photo credit: www.fool.com The recent announcement from a significant player in the pharmaceutical industry indicates that not all acquisitions yield...

AbbVie Shares Plummet Following Disappointing Results from Schizophrenia Drug Trials

Photo credit: www.investopedia.com AbbVie Faces Setback as Emraclidine Trials Fall Short Key Takeaways Shares of AbbVie experienced a sharp decline on Monday...

AbbVie Stock Falls as Schizophrenia Drug Trial Fails to Meet Primary Endpoint – Investing.com

Photo credit: www.investing.com Investing.com - AbbVie (NYSE: ) has revealed that its two Phase 2 trials for a treatment targeting...